After 35 years of tireless service to the people and patients of Vanderbilt University Medical Center, C. Wright Pinson, MBA, MD, Deputy CEO and Chief Health System Officer, will step down from that role.

VUMC researchers applied the new approach to large GWAS datasets for breast, prostate and lung cancers, and three brain disorders.

Research could lead to improved diagnosis and the first effective treatment for the disorder, called “clonal hematopoiesis of indeterminate potential,” or CHIP. 

The list recognizes both the scientific achievements of individual scientists and “their profound impact on tackling broader societal challenges.”

Three grants, totaling over $22 million, were awarded by the National Institutes of Health’s National Heart, Lung, and Blood Institute and will be led by a team of VUMC investigators.

Young patients with thyroid, lung, ovarian and colorectal cancers reported the lowest prevalence of a fertility preservation discussion.

Family establishes ERDie Project in memory of daughter, Emma Ryleigh Dixon, to support pediatric bone cancer research at Monroe Carell Jr. Children’s Hospital at Vanderbilt.